ORMP — ORAMED PHARMACEUTICALS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 89 家机构在其最新 13F 申报中持有 ORMP(ORAMED PHARMACEUTICALS INC),合计申报市值 $82.75M,对应 17.23M 股。按股数计算较上季度增持 16.5%(+2.16M 股),申报市值环比上升 64.7%。持仓集中度较高:前五大持有人占申报市值的 65.2%,前十大的集中度为 80.9%。
与上一季度相比,32 家新建仓位、22 家加仓、19 家减仓、8 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ORAMED PHARMACEUTICALS INC(ORMP)的主要机构持有人包括 MERCER GLOBAL ADVISORS INC /ADV、Aquamarine Financial (Cayman) Ltd、Murchinson Ltd.,按 13F 申报市值在本页 151 家持有人中排名居前。
ORMP 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 67 | 12.67M | $59.10M | +13.2% |
| Q2 2026 | 89 | 17.23M | $82.75M | +16.5% |
| Q1 2026 | 65 | 13.26M | $45.10M | -1.9% |
| Q4 2025 | 57 | 11.16M | $31.82M | -6.0% |
| Q3 2025 | 49 | 9.26M | $24.45M | +2.6% |
| Q2 2025 | 49 | 7.24M | $16.29M | -2.7% |
| Q1 2025 | 51 | 7.76M | $16.61M | +3.8% |
| Q4 2024 | 56 | 7.54M | $18.25M | +5.4% |
表内 8 个季度中,机构持股合计增加 68%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2026(+16.5%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 2.65M | $12.39M | 0.64% | 增持 | |
| 2.14M | $10.00M | 1.91% | 增持 | |
| 2.00M | $9.33M | 6.74% | 持有 | |
| 1.84M | $8.59M | 0.00% | 增持 | |
| 884.39K | $4.13M | 2.20% | 增持 | |
| 500.92K | $2.34M | 0.00% | 持有 | |
| 466.72K | $2.18M | 0.00% | 新进 | |
| 294.27K | $1.37M | 0.00% | 增持 | |
| 239.05K | $1.12M | 0.00% | 增持 | |
| 233.02K | $1.09M | 0.00% | 持有 | |
| 211.25K | $986.61K | 0.00% | 增持 | |
| 188.50K | $880.29K | 0.00% | 增持 | |
| 107.99K | $504.30K | 0.00% | 增持 | |
| 97.52K | $455.43K | 0.00% | 增持 | |
| 79.25K | $370.12K | 0.00% | 持有 | |
| 67.94K | $317.27K | 0.01% | 减持 | |
| 75.77K | $312.94K | 0.00% | 减持 | |
| 59.77K | $279.15K | 0.00% | 持有 | |
| 52.82K | $246.68K | 0.00% | 增持 | |
| 50.37K | $235.23K | 0.00% | 增持 | |
| 33.97K | $158.66K | 0.00% | 新进 | |
| 32.48K | $151.67K | 0.00% | 持有 | |
| 29.06K | $135.71K | 0.00% | 减持 | |
| 27.60K | $128.88K | 0.00% | 减持 | |
| 24.46K | $114.24K | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.81M | $18.33M | 0.03% | 增持 | |
| 2.51M | $12.08M | 0.67% | 增持 | |
| 2.00M | $9.61M | 6.28% | 增持 | |
| 1.61M | $7.74M | 0.00% | 增持 | |
| 1.29M | $6.21M | 1.68% | 减持 | |
| 866.27K | $4.17M | 2.37% | 减持 | |
| 578.64K | $2.78M | 0.06% | 减持 | |
| 500.69K | $2.41M | 0.00% | 新进 | |
| 500.69K | $2.41M | 0.00% | 增持 | |
| 253.29K | $1.22M | 0.00% | 新进 | |
| 233.02K | $1.12M | 0.00% | 持有 | |
| 229.88K | $1.11M | 0.00% | 新进 | |
| 202.61K | $973.78K | 0.00% | 增持 | |
| 184.92K | $889.47K | 0.00% | 新进 | |
| 183.80K | $884.08K | 0.00% | 增持 | |
| 166.00K | $798.46K | 0.00% | 增持 | |
| 150.69K | $724.84K | 0.00% | 增持 | |
| 133.80K | $643.58K | 0.00% | 新进 | |
| 113.35K | $545.21K | 0.00% | 增持 | |
| 102.96K | $495.25K | 0.00% | 减持 | |
| 101.95K | $490.39K | 0.00% | 减持 | |
| 97.58K | $469.00K | 0.00% | 增持 | |
| 89.30K | $429.53K | 0.01% | 减持 | |
| 84.35K | $405.71K | 0.01% | 减持 | |
| 83.63K | $402.28K | 0.00% | 新进 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.17M | $10.77M | 6.91% | 持有 | |
| 2.11M | $7.18M | 0.53% | 增持 | |
| 1.91M | $6.50M | 0.01% | 新进 | |
| 1.64M | $5.58M | 5.76% | 减持 | |
| 1.32M | $4.47M | 1.46% | 减持 | |
| 600.72K | $2.04M | 0.05% | 减持 | |
| 259.61K | $882.68K | 0.00% | 持有 | |
| 233.02K | $792.26K | 0.00% | 持有 | |
| 158.21K | $537.74K | 0.00% | 增持 | |
| 157.59K | $535.79K | 0.00% | 增持 | |
| 155.48K | $528.63K | 0.01% | 新进 | |
| 147.70K | $502.18K | 0.00% | 持有 | |
| 146.15K | $496.92K | 0.00% | 增持 | |
| 136.22K | $463.14K | 0.00% | 增持 | |
| 116.36K | $395.63K | 0.00% | 新进 | |
| 98.63K | $335.34K | 0.00% | 减持 | |
| 97.30K | $330.82K | 0.01% | 新进 | |
| 92.19K | $313.45K | 0.00% | 增持 | |
| 52.54K | $178.64K | 0.00% | 减持 | |
| 51.67K | $175.68K | 0.00% | 新进 | |
| 50.21K | $170.70K | 0.00% | 增持 | |
| 35.31K | $120.06K | 0.01% | 增持 | |
| 32.48K | $110.42K | 0.00% | 新进 | |
| 32.31K | $109.84K | 0.00% | 增持 | |
| 27.50K | $93.00K | 0.00% | 减持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.17M | $9.03M | 7.80% | 持有 | |
| 2.00M | $5.70M | 5.54% | 新进 | |
| 1.97M | $5.62M | 0.46% | 持有 | |
| 1.34M | $3.82M | 1.11% | 减持 | |
| 612.16K | $1.74M | 0.05% | 减持 | |
| 259.06K | $738.31K | 0.00% | 新进 | |
| 233.02K | $664.10K | 0.00% | 持有 | |
| 196.02K | $558.66K | 0.00% | 增持 | |
| 150.47K | $428.84K | 0.00% | 增持 | |
| 147.50K | $420.38K | 0.00% | 减持 | |
| 142.24K | $405.39K | 0.00% | 减持 | |
| 130.59K | $372.17K | 0.00% | 持有 | |
| 90.21K | $257.10K | 0.00% | 减持 | |
| 78.26K | $223.04K | 0.00% | 增持 | |
| 58.27K | $166.07K | 0.00% | 增持 | |
| 46.09K | $131.00K | 0.00% | 新进 | |
| 43.73K | $124.64K | 0.00% | 增持 | |
| 42.95K | $122.40K | 0.01% | 持有 | |
| 41.73K | $118.94K | 0.00% | 新进 | |
| 38.18K | $108.82K | 0.00% | 增持 | |
| 25.98K | $74.05K | 0.00% | 减持 | |
| 25.44K | $72.51K | 0.00% | 新进 | |
| 24.28K | $69.20K | 0.00% | 持有 | |
| 23.14K | $65.96K | 0.01% | 新进 | |
| 23.00K | $65.55K | 0.07% | 新进 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.17M | $8.36M | 7.66% | 增持 | |
| 1.97M | $5.21M | 0.53% | 新进 | |
| 1.75M | $4.62M | 1.15% | 持有 | |
| 845.39K | $2.23M | 0.06% | 持有 | |
| 233.02K | $615.17K | 0.00% | 持有 | |
| 149.67K | $395.12K | 0.00% | 增持 | |
| 148.90K | $393.10K | 0.00% | 增持 | |
| 147.49K | $389.37K | 0.00% | 减持 | |
| 130.09K | $343.43K | 0.00% | 增持 | |
| 111.71K | $294.91K | 0.00% | 增持 | |
| 109.73K | $289.70K | 0.00% | 增持 | |
| 59.66K | $157.50K | 0.00% | 增持 | |
| 52.90K | $139.66K | 0.00% | 减持 | |
| 42.95K | $113.38K | 0.01% | 持有 | |
| 36.83K | $97.22K | 0.00% | 增持 | |
| 29.87K | $78.85K | 0.00% | 减持 | |
| 28.24K | $74.56K | 0.00% | 减持 | |
| 24.28K | $64.10K | 0.00% | 持有 | |
| 23.89K | $63.06K | 0.00% | 新进 | |
| 23.20K | $61.25K | 0.00% | 持有 | |
| 19.59K | $51.72K | 0.00% | 持有 | |
| 18.80K | $46.62K | 0.00% | 持有 | |
| 16.92K | $44.68K | 0.00% | 减持 | |
| 16.75K | $44.22K | 0.02% | 持有 | |
| 13.59K | $35.86K | 0.00% | 减持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.08M | $6.94M | 5.25% | 增持 | |
| 1.75M | $3.94M | 1.41% | 持有 | |
| 845.39K | $1.90M | 0.06% | 持有 | |
| 233.02K | $524.29K | 0.00% | 减持 | |
| 166.90K | $375.52K | 0.00% | 增持 | |
| 144.20K | $324.45K | 0.00% | 增持 | |
| 143.41K | $322.66K | 0.00% | 减持 | |
| 85.57K | $192.53K | 0.00% | 减持 | |
| 84.78K | $190.75K | 0.19% | 减持 | |
| 78.30K | $176.18K | 0.00% | 增持 | |
| 66.45K | $149.51K | 0.00% | 增持 | |
| 60.45K | $136.01K | 0.00% | 减持 | |
| 47.59K | $107.00K | 0.00% | 减持 | |
| 46.07K | $103.66K | 0.00% | 减持 | |
| 42.95K | $96.63K | 0.01% | 持有 | |
| 42.37K | $95.33K | 0.00% | 减持 | |
| 32.09K | $72.21K | 0.00% | 减持 | |
| 24.28K | $54.63K | 0.00% | 减持 | |
| 23.40K | $52.65K | 0.00% | 减持 | |
| 23.20K | $52.20K | 0.00% | 减持 | |
| 22.80K | $51.30K | 0.00% | 增持 | |
| 20.99K | $47.22K | 0.00% | 持有 | |
| 19.59K | $44.08K | 0.00% | 持有 | |
| 18.80K | $40.98K | 0.00% | 增持 | |
| 16.75K | $37.69K | 0.02% | 持有 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 500.69K 股 · $2.41M
- Goldman Sachs Group 253.29K 股 · $1.22M
- VANGUARD PORTFOLIO MANAGEMENT LLC 229.88K 股 · $1.11M
- Northern Trust Corp 184.92K 股 · $889.47K
- STRS OHIO 133.80K 股 · $643.58K
- Charles Schwab Investment Management 83.63K 股 · $402.28K
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 83.63K 股 · $402.28K
- Sixth Street Partners Management Company, L.P. 83.63K 股 · $402.28K
- BNY Mellon 79.25K 股 · $381.22K
- Nuveen, LLC 46.40K 股 · $223.20K
- Deutsche Bank AG 33.20K 股 · $159.68K
- RHUMBLINE ADVISERS 30.62K 股 · $147.28K
完全清仓(较上季)
- Point72 Asset Management 卖出 26.05K 股 · $88.58K
- Qube Research & Technologies Ltd 卖出 23.50K 股 · $79.91K
- Catalyst Funds Management Pty Ltd 卖出 23.50K 股 · $79.90K
- OMERS ADMINISTRATION Corp 卖出 18.40K 股 · $62.56K
- Kathmere Capital Management, LLC 卖出 15.07K 股 · $51.24K
- AXQ CAPITAL, LP 卖出 11.33K 股 · $38.51K
- MAI Capital Management 卖出 2.06K 股 · $6.99K
- McIlrath & Eck, LLC 卖出 1.00K 股 · $3.40K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | 2.65M | 2.51M | 2.11M | 1.97M | 1.97M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Murchinson Ltd. | 2.14M | 1.29M | 1.32M | 1.34M | 1.75M | 1.75M | 1.75M | 1.75M | 1.71M | 1.70M | 1.38M | 1.05M | — | — | — | — | — | — | — | — |
| Gem Investment Advisors, LLC | 2.00M | 2.00M | 1.64M | 2.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 1.84M | 1.61M | 92.19K | 90.21K | 109.73K | 85.57K | 92.32K | 93.70K | 92.01K | — | — | — | — | — | — | — | — | — | — | — |
| BML Capital Management, LLC | 884.39K | 866.27K | 3.17M | 3.17M | 3.17M | 3.08M | 3.02M | 2.64M | 2.19M | 1.35M | 844.50K | 1.26M | 781.29K | — | — | — | — | — | — | — |
| Geode Capital Management | 500.92K | 500.69K | 24.28K | 24.28K | 24.28K | 24.28K | 25.45K | 25.45K | 25.45K | 25.45K | 25.45K | 25.45K | 20.91K | 20.91K | 18.13K | 18.13K | 18.13K | 18.13K | 321.16K | 245.34K |
| STATE STREET CORP | 466.72K | — | — | — | — | 66.45K | 65.22K | 60.82K | 60.06K | 59.26K | 58.13K | 57.97K | 56.81K | — | — | — | — | — | — | — |
| Renaissance Technologies | 294.27K | 183.80K | 147.70K | 147.50K | 148.90K | 144.20K | 142.50K | 151.81K | 245.30K | 230.80K | 122.10K | 341.07K | 44.30K | 33.70K | 11.90K | — | — | 359.70K | — | 203.20K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 239.05K | 229.88K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Rathbones Group PLC | 233.02K | 233.02K | 233.02K | 233.02K | 233.02K | 233.02K | 236.80K | 289.80K | 289.80K | 289.80K | 289.80K | 289.80K | 289.80K | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 211.25K | 202.61K | 158.21K | 150.47K | 147.49K | 166.90K | 141.08K | 119.00K | 48.80K | 31.47K | 20.70K | — | 27.29K | — | — | — | — | — | — | — |
| STRS OHIO | 188.50K | 133.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 107.99K | 43.36K | 14.05K | 17.63K | 16.92K | 32.09K | 35.83K | 34.63K | 44.65K | 45.43K | 44.71K | 64.24K | 60.51K | 43.79K | 284.14K | 316.39K | 527.11K | 686.85K | 594.03K | 386.62K |
| UBS Group AG | 97.52K | 67.67K | 11.67K | 2.58K | 357 | 12.78K | 35.58K | 112.98K | 28.18K | 9.29K | 4.65K | 5.07K | 6.21K | 6.14K | 99.13K | 10.71K | 8.41K | 4.55K | 3.03K | 13.68K |
| BNY Mellon | 79.25K | 79.25K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 97.28K | 81.92K |
| RITHOLTZ WEALTH MANAGEMENT | 67.94K | 84.35K | 155.48K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 75.77K | 102.96K | 116.36K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | 59.77K | 59.77K | 32.31K | 19.59K | 19.59K | 19.59K | 19.59K | 19.59K | 19.59K | 19.59K | 19.59K | 19.29K | 18.76K | — | — | — | — | — | — | — |
| Connor, Clark & Lunn Investment Management Ltd. | 52.82K | 25.21K | 50.21K | 43.73K | 28.24K | 60.45K | 87.14K | 107.06K | 111.52K | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 50.37K | 46.40K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold ORMP?
As of 2026-Q2, 89 institutional funds reported holding ORMP (ORAMED PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $82.75M.
How many shares of ORMP do institutions own?
13F filers reported 17.23M shares of ORMP, worth $82.75M in aggregate at the end of 2026-Q2.
Is institutional ownership of ORMP rising or falling?
Share counts moved +16.5% versus the prior quarter — accumulation.
Who are the top institutional holders of ORMP?
The largest 13F holders are MERCER GLOBAL ADVISORS INC /ADV, Aquamarine Financial (Cayman) Ltd, Murchinson Ltd., Gem Investment Advisors, LLC, BlackRock Inc; the top 25 are ranked at the top of this page.
Who are the major shareholders of ORAMED PHARMACEUTICALS INC?
The major shareholders of ORAMED PHARMACEUTICALS INC (ORMP) by reported 13F value are MERCER GLOBAL ADVISORS INC /ADV, Aquamarine Financial (Cayman) Ltd, Murchinson Ltd., Gem Investment Advisors, LLC, BlackRock Inc, among 151 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.